Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy
Karen M. Ryan, Kelly A. Allers, Declan M. McLoughlin, et al.
Brain Behavior and Immunity (2019) Vol. 83, pp. 153-162
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications
Mustafa N. Mithaiwala, Danielle Santana‐Coelho, Grace A. Porter, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1548-1548
Open Access | Times Cited: 117
Peripheral and central kynurenine pathway abnormalities in major depression
Elisabeth Paul, Lilly Schwieler, Sophie Erhardt, et al.
Brain Behavior and Immunity (2022) Vol. 101, pp. 136-145
Open Access | Times Cited: 79
How Microbes Affect Depression: Underlying Mechanisms via the Gut–Brain Axis and the Modulating Role of Probiotics
Kazunori Suda, Kazunori Matsuda
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1172-1172
Open Access | Times Cited: 78
Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
Ellen Doney, Alice Cadoret, Laurence Dion‐Albert, et al.
European Journal of Neuroscience (2021) Vol. 55, Iss. 9-10, pp. 2851-2894
Open Access | Times Cited: 83
Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders
Katrien Skorobogatov, Livia De Picker, Robert Verkerk, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 61
Biophilic environment with visual-olfactory stimuli contributes to psychophysiological restoration and cognitive enhancement
Zhaoming Li, Wenzhu Zhang, Jingxian Cui, et al.
Building and Environment (2024) Vol. 250, pp. 111202-111202
Closed Access | Times Cited: 9
Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period
Bernadett Tuka, Aliz Nyári, Edina Katalin Cseh, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 45
The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis
Abbas F. Almulla, Yanin Thipakorn, Asara Vasupanrajit, et al.
Brain Behavior & Immunity - Health (2022) Vol. 26, pp. 100537-100537
Open Access | Times Cited: 33
The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis
Abbas F. Almulla, Yanin Thipakorn, Asara Vasupanrajit, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3112-3112
Open Access | Times Cited: 21
The Kynurenine Pathway in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Blood Concentrations of Tryptophan and Its Catabolites
Daniele Cavaleri, Cristina Crocamo, Pietro Morello, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 583-583
Open Access | Times Cited: 4
Inflammatory markers associated with electroconvulsive therapy response in patients with depression: A meta-analysis
Annelies Dellink, Gertjan Vanderhaegen, Violette Coppens, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 170, pp. 106060-106060
Open Access
Central levels of tryptophan metabolites in subjects with bipolar disorder
Ada Trepci, Carl M. Sellgren, Erik Pålsson, et al.
European Neuropsychopharmacology (2020) Vol. 43, pp. 52-62
Open Access | Times Cited: 30
Quinolinic acid, a kynurenine/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus
Erik Anderson, Joanna Fishbein, Joseph Hong, et al.
Lupus Science & Medicine (2021) Vol. 8, Iss. 1, pp. e000559-e000559
Open Access | Times Cited: 25
Analysis of tryptophan metabolites and related compounds in human and murine tissue: development and validation of a quantitative and semi-quantitative method using high resolution mass spectrometry
Sandy Abujrais, S. J. Kumari A. Ubhayasekera, Jonas Bergquist
Analytical Methods (2024) Vol. 16, Iss. 7, pp. 1074-1082
Open Access | Times Cited: 3
Is the Therapeutic Mechanism of Repetitive Transcranial Magnetic Stimulation in Cognitive Dysfunctions of Depression Related to the Neuroinflammatory Processes in Depression?
Hiroshi Tateishi, Yoshito Mizoguchi, Akira Monji
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 14
Blood plasma B vitamins in depression and the therapeutic response to electroconvulsive therapy
Karen M. Ryan, Kelly A. Allers, Andrew Harkin, et al.
Brain Behavior & Immunity - Health (2020) Vol. 4, pp. 100063-100063
Open Access | Times Cited: 19
Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: A link to the monocyte inflammatory state of patients
Gara Arteaga-Henríquez, Bianka Burger, Elif Weidinger, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 107, pp. 110226-110226
Open Access | Times Cited: 19
A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study
Niyazi Samet Yılmaz, Bayram Şen, Filiz Karadağ, et al.
Journal of Neural Transmission (2022) Vol. 129, Iss. 12, pp. 1513-1526
Closed Access | Times Cited: 10
Reviewing the role of gut microbiota in the pathogenesis of depression and exploring new therapeutic options
Wenjie Han, Na Wang, Mengzhen Han, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 10
The changes in kynurenine metabolites induced by rTMS in treatment-resistant depression: A pilot study
Hiroshi Tateishi, Daiki Setoyama, Dongchon Kang, et al.
Journal of Psychiatric Research (2021) Vol. 138, pp. 194-199
Open Access | Times Cited: 14
Studies on the Changes of Pharmacokinetics Behaviors of Phytochemicals and the Influence on Endogenous Metabolites After the Combination of Radix Bupleuri and Radix Paeoniae Alba Based on Multi-Component Pharmacokinetics and Metabolomics
Congcong Chen, Qicai Yin, Junshen Tian, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 13
Recent Progress in Mass Spectrometry-Based Metabolomics in Major Depressive Disorder Research
Mingxia Liu, Wen Ma, Yi He, et al.
Molecules (2023) Vol. 28, Iss. 21, pp. 7430-7430
Open Access | Times Cited: 5
Changes in Tryptophan-Kynurenine Metabolism in Patients with Depression Undergoing ECT—A Systematic Review
Tore Ivar Malmei Aarsland, Johanne Telnes Instanes, Maj-Britt Rocio Posserud, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1439-1439
Open Access | Times Cited: 8
Mood, Cognitive Function, and Plasma Kynurenine Metabolites Responses Following Severe Changes in Physical Activity
Sigitas Kamandulis, Inga Lukonaitienė, Audrius Sniečkus, et al.
Medicine & Science in Sports & Exercise (2024) Vol. 56, Iss. 10, pp. 2007-2015
Closed Access | Times Cited: 1
Serum metabolic profile evidence for relationship between schizophrenia and depression: An untargeted metabolomics
Jing Zhang, Ruru Ren, Shuqin Ding, et al.
Biomedical Chromatography (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top